Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Investigational

A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Empasiprubart

Contact Research Centre

Bladder transitional cell carcinoma+1

Recruiting

InvestigationalNo placebo

Study of MK-3120 for patients with high-risk non-muscle invasive bladder cancer who have not received or have received BCG treatment

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:SKB410

Contact Research Centre

Squamous cell carcinoma of skin

Recruiting

InvestigationalNo placebo

A study of onfekafusp alfa and bifikafusp alfa injected into tumors for patients with advanced skin squamous cell cancer who did not respond to or could not tolerate previous treatment

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bifikafusp Alfa

Contact Research Centre

Transitional cell carcinoma metastatic

Recruiting

Registered drugNo placebo

Study of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

Registered drug

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Cutaneous lupus erythematosus

Recruiting

Registered drugNo placebo

A Study of Anifrolumab for Patients with Cutaneous Lupus Erythematosus to Measure Changes in Skin and Blood Inflammation and Clinical Outcomes

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Renal transplant

Recruiting

Registered drug

A Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Felzartamab

Contact Research Centre

A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

Recruiting

Registered drug

A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

Registered drug

Austria

Participants:0–17 years · 18–64 years
Substances:Sodium Chloride

Contact Research Centre

Pulmonary hypertension

Recruiting

Investigational

Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Treprostinil Palmitil

Contact Research Centre

Cervix carcinoma

Recruiting

Registered drugNo placebo

A Study of Sacituzumab Tirumotecan, Pembrolizumab, and Bevacizumab for Patients with Metastatic Cervical Cancer That Has Spread or Returned

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Testing zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Registered drugNo placebo

A Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Amivantamab

Contact Research Centre

Find therapies in clinical trials near you – page 10

838 trials match your criteria

Chronic inflammatory demyelinating polyradiculoneuropathy

A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

Bladder transitional cell carcinoma+1

Study of MK-3120 for patients with high-risk non-muscle invasive bladder cancer who have not received or have received BCG treatment

Squamous cell carcinoma of skin

A study of onfekafusp alfa and bifikafusp alfa injected into tumors for patients with advanced skin squamous cell cancer who did not respond to or could not tolerate previous treatment

Transitional cell carcinoma metastatic

Study of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy

Acute myeloid leukaemia

Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

Cutaneous lupus erythematosus

A Study of Anifrolumab for Patients with Cutaneous Lupus Erythematosus to Measure Changes in Skin and Blood Inflammation and Clinical Outcomes

Renal transplant

A Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation

A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

Pulmonary hypertension

Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

Cervix carcinoma

A Study of Sacituzumab Tirumotecan, Pembrolizumab, and Bevacizumab for Patients with Metastatic Cervical Cancer That Has Spread or Returned

Non-small cell lung cancer

Testing zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery

Squamous cell carcinoma of head and neck

A Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.